Russell J. Cox
2014 - Jazz Pharmaceuticals
In 2014, Russell J. Cox earned a total compensation of $5.5M as Executive Vice President and COO at Jazz Pharmaceuticals, a 131% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $320,000 |
---|---|
Option Awards | $1,991,469 |
Salary | $493,462 |
Stock Awards | $2,681,998 |
Other | $11,759 |
Total | $5,498,688 |
Cox received $2.7M in stock awards, accounting for 49% of the total pay in 2014.
Cox also received $320K in non-equity incentive plan, $2M in option awards, $493.5K in salary and $11.8K in other compensation.
Rankings
In 2014, Russell J. Cox's compensation ranked 1,361st out of 13,032 executives tracked by ExecPay. In other words, Cox earned more than 89.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,361 out of 13,032 | 90th |
Division Manufacturing | 489 out of 4,966 | 90th |
Major group Chemicals And Allied Products | 155 out of 1,686 | 91st |
Industry group Drugs | 121 out of 1,365 | 91st |
Industry Pharmaceutical Preparations | 106 out of 1,043 | 90th |
Source: SEC filing on June 20, 2017.
Cox's colleagues
We found five more compensation records of executives who worked with Russell J. Cox at Jazz Pharmaceuticals in 2014.
2014
Bruce Cozadd
Jazz Pharmaceuticals
Chief Executive Officer
2014
Suzanne Hooper
Jazz Pharmaceuticals
Executive Vice President and GC
2014
Matthew Young
Jazz Pharmaceuticals
Chief Financial Officer
2014
Michael Miller
Jazz Pharmaceuticals
Senior Vice President, U.S. Commercial
2014
Kathryn Falberg
Jazz Pharmaceuticals